South Wales, Oct. 24 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "NXERA" on Oct. 17. The details about the trademark application no. UK00004279986 published in the journal no. 2025/043 (Oct. 24).
With Gill Jennings & Every LLP as representative, Nxera Pharma Co., Ltd. filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Software, application software, computer software, computer software platforms, artificial intelligence, generative artificial intelligence software, generative design software, deep learning software, neural networks software and machine learning software, large language models software, frontier models software, foundation models software, retrieval augmented generation trained models software, knowledge graphs software, all being in the field of life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; computer software for accessing, browsing and searching online databases all being in the field of life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; computer software for searching, tracking, modelling, exploration and analysis of data all being in the field of life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; artificial intelligence software for searching, tracking, modelling, exploration and analysis of data of data all being in the field of life sciences, chemical and biological drug discovery, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; databases; computer databases; data banks; electronic databases; interactive databases; data processing software.
Class 35 : Database management; computer database management; collection and compilation of data; compilation and systemisation of information and data in computer databases; compilation of information and data relating to life sciences, chemical and biological drug discovery, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; data processing, systemisation and management; data processing services; providing business statistical information for use in predictive analytics and predictive modelling via computer databases; information, advisory and consultancy services relating to all of the aforesaid services.
Class 42 : Artificial intelligence as a service [AIaaS], software as a service, platform as a service [PaaS], all being in the field of life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; design and development of computer software all being in the field of life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; providing online non-downloadable computer software all being in the field of life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; providing online non-downloadable computer software for searching, tracking, modelling, exploration and analysis of data all being in the field of life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; computer programming; compilation of scientific information; preparation of scientific and technological reports; provision of scientific and technical information and data relating to life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; information, advisory and consultancy services relating to all of the aforesaid services.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004279986
Disclaimer: Curated by HT Syndication.
